human growth hormone

How WADA Dropped the Ball on the Veerpalu Doping Case

When Andrus Veerpalu tested positive for recombinant human grown hormone in both his A and B samples in the winter of 2011, FIS used a peer-reviewed, reliable test to detect the abnormalities and seemed to have a slam-dunk case. In a highly unusual appeals case that surprised scientists and anti-doping administrators alike, the Court of Arbitration for Sport found that WADA had made missteps in setting detection limits. Here's how Veerpalu won a case even though CAS was sure he was guilty.

The International Ski Federation (FIS) Doping Panel came to a final decision on Monday in Andrus Veerpalu’s case. The Estonian champion’s positive drug test from this winter, which came just before World Championships in Oslo and his abrupt retirement, still stands. His two-year ban from competition was extended to three; the end of the sentence in 2014 falls precisely on the closing ceremonies in Sochi. In February, the World Anti-Doping Agency (WADA) found Veerpalu to...